Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.120 GeneticVariation disease BEFREE Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia, is associated with mutations in fibroblast growth factor receptor 2 (FGFR2) (refs 1-3). 7493034 1995
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.120 GeneticVariation disease BEFREE The variable presentation should remind paediatricians to consider mutations in fibroblast growth factor receptor 2 among the aetiologies of exophthalmos. 20163525 2010
Entrez Id: 4784
Gene Symbol: NFIX
NFIX
0.100 GeneticVariation disease CLINVAR
Entrez Id: 8925
Gene Symbol: HERC1
HERC1
0.100 GeneticVariation disease CLINVAR A splice site mutation in HERC1 leads to syndromic intellectual disability with macrocephaly and facial dysmorphism: Further delineation of the phenotypic spectrum. 27108999 2016
Entrez Id: 56052
Gene Symbol: ALG1
ALG1
0.100 GeneticVariation disease CLINVAR
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 GeneticVariation disease CLINVAR
Entrez Id: 8785
Gene Symbol: MATN4
MATN4
0.100 GeneticVariation disease CLINVAR
Entrez Id: 106865367
Gene Symbol: MRD2
MRD2
0.020 GeneticVariation disease BEFREE Exophthalmos, midpupil to lower eyelid margin distances (MRD2) at 11 meridians, and globe position were measured and compared according to the types of decompression. 27997462 2017
Entrez Id: 51251
Gene Symbol: NT5C3A
NT5C3A
0.010 GeneticVariation disease BEFREE Patients most commonly presented with a cranial nerve (CN) palsy involving CN III-VI (70%), a visual deficit (62%), headaches (52%), or proptosis (44%). 30771770 2019
Entrez Id: 80781
Gene Symbol: COL18A1
COL18A1
0.010 GeneticVariation disease BEFREE The patient was started on a trial of the antiangiogenic agent sirolimus (also known as rapamycin), and after 6 months of treatment showed clinical improvement in proptosis supported by radiologic evidence of regression in the larger, left orbital mass, with stability of the smaller, right orbital mass. 27065430 2017
Entrez Id: 3596
Gene Symbol: IL13
IL13
0.010 GeneticVariation disease BEFREE IL-13 -1112C/T was associated with IgE elevation (P = 0.044) and 2044G/A with proptosis (P = 0.02), but these associations became insignificant after Bonferroni correction (P = 0.22 and 0.10, respectively). 18296657 2008
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.010 GeneticVariation disease BEFREE Multivariate analysis (step) showed that the association of either proptosis or CAS with the PPAR gamma gene variant remained significant when age, smoking and TSH-Rab levels were taken into account (P < 0.01). 18624999 2009
Entrez Id: 7253
Gene Symbol: TSHR
TSHR
0.130 Biomarker disease BEFREE These findings, combined with the clinical conditions-an ophthalmologic evaluation (that showed the presence of exophthalmos without lagophthalmos and visual acuity deficiency), thyroid ultrasound, and TSH receptor antibody positivity-led to a diagnosis of Graves' disease. 30626069 2019
Entrez Id: 7253
Gene Symbol: TSHR
TSHR
0.130 Biomarker disease HPO
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.120 Biomarker disease HPO
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.100 Biomarker disease HPO
Entrez Id: 6016
Gene Symbol: RIT1
RIT1
0.100 Biomarker disease HPO
Entrez Id: 4784
Gene Symbol: NFIX
NFIX
0.100 Biomarker disease HPO
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.100 Biomarker disease HPO
Entrez Id: 7068
Gene Symbol: THRB
THRB
0.100 Biomarker disease HPO
Entrez Id: 100151683
Gene Symbol: RNU4ATAC
RNU4ATAC
0.100 Biomarker disease HPO
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.100 Biomarker disease HPO
Entrez Id: 29968
Gene Symbol: PSAT1
PSAT1
0.100 Biomarker disease HPO
Entrez Id: 6452
Gene Symbol: SH3BP2
SH3BP2
0.100 Biomarker disease HPO
Entrez Id: 5889
Gene Symbol: RAD51C
RAD51C
0.100 Biomarker disease HPO